These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 71463)

  • 61. Inability to demonstrate lytic antibodies to autologous leukaemia cells in the sera from remission patients with acute myelogenous leukaemia treated with active specific immunotherapy.
    Chapuis BJ; Powles R; Alexander P
    Clin Exp Immunol; 1978 May; 32(2):253-8. PubMed ID: 276431
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Acute myelocytic leukaemia and leukaemia-associated antigens in sisters.
    Pendergrass TW; Mann DL; Stoller RG; Halterman RH; Fraumeni JF
    Lancet; 1975 Sep; 2(7932):429-31. PubMed ID: 51238
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Blood group change in acute myeloid leukaemia.
    Hocking DR
    Med J Aust; 1971 Oct; 2(18):902-3. PubMed ID: 5288193
    [No Abstract]   [Full Text] [Related]  

  • 64. [ABO AND RH PHENOTYPES IN THE SARDINIAN POPULATION].
    AJMAR F; TIZIANELLO A; PANNACCIULLI I; SALVIDIO E
    Boll Soc Ital Biol Sper; 1963 Dec; 39():1467-9. PubMed ID: 14122293
    [No Abstract]   [Full Text] [Related]  

  • 65. Active immunotherapy in acute myelogenous leukaemia and the induction of second and subsequent remissions.
    Harris R; Zuhrie SR; Freeman CB; Taylor GM; MacIver JE; Geary CG; Delamore IW; Hull PJ; Tooth JA
    Br J Cancer; 1978 Feb; 37(2):282-8. PubMed ID: 272913
    [TBL] [Abstract][Full Text] [Related]  

  • 66. BLOOD GROUPS OF THE ABO-SYSTEM AND THE RH-O(D) FACTOR IN LIVER CIRRHOSIS)(GER).
    KORDAC V
    Z Gesamte Inn Med; 1965 May; 20():290-2. PubMed ID: 14306486
    [No Abstract]   [Full Text] [Related]  

  • 67. ABO and RhD blood group in leukemic patients.
    Moszczyński P; Lisiewiez J
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1973; 100(4):395-400. PubMed ID: 4132193
    [No Abstract]   [Full Text] [Related]  

  • 68. Factors influencing prognosis in adults with acute myelogenous leukaemia.
    Crowther D; Beard ME; Bateman CJ; Sewell RL
    Br J Cancer; 1975 Oct; 32(4):456-64. PubMed ID: 1082343
    [TBL] [Abstract][Full Text] [Related]  

  • 69. The distribution, age effects and disease associations of HLA antigens and other blood group markers in a random sample of an elderly population.
    Yarnell JW; St Leger AS; Balfour IC; Russell RB
    J Chronic Dis; 1979; 32(8):555-61. PubMed ID: 112106
    [No Abstract]   [Full Text] [Related]  

  • 70. Association of ABO and Rh(D) blood groups with filariasis.
    Srisailapathy CR; Ramesh A; Ganesan J
    Hum Hered; 1990; 40(6):381-5. PubMed ID: 2128074
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Letter: Survival in acute myeloid leukaemia.
    Lancet; 1975 Nov; 2(7944):1091. PubMed ID: 53575
    [No Abstract]   [Full Text] [Related]  

  • 72. [The ABO and Rh (D) blood groups in the department of Sarthe].
    Kherumian R; Schiffer C
    Transfusion (Paris); 1967; 10(1):11-6. PubMed ID: 4963379
    [No Abstract]   [Full Text] [Related]  

  • 73. Distribution of ABO/Rh blood groups and their association with hepatitis B virus infection in 3.8 million Chinese adults: A population-based cross-sectional study.
    Liu J; Zhang S; Liu M; Wang Q; Shen H; Zhang Y
    J Viral Hepat; 2018 Apr; 25(4):401-411. PubMed ID: 29193618
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Active specific immunotherapy for acute myelogenous leukaemia.
    Powles R
    Johns Hopkins Med J Suppl; 1974; 3():333-40. PubMed ID: 4609353
    [No Abstract]   [Full Text] [Related]  

  • 75. Immunotherapy for acute myelogenous leukaemia: a controlled clinical study 2 1/2 years after entry of the last patient.
    Powles RL; Russell J; Lister TA; Oliver T; Whitehouse JM; Malpas J; Chapuis B; Crowther D; Alexander P
    Br J Cancer; 1977 Mar; 35(3):265-72. PubMed ID: 322689
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Cell-mediated immune responses between HLA-identical siblings: recognition of antigenic changes associated with acute myelogenous leukaemia.
    Zier KS; Huber C; Albert E; Braunsteiner H
    Clin Exp Immunol; 1980 Apr; 40(1):136-46. PubMed ID: 6446429
    [TBL] [Abstract][Full Text] [Related]  

  • 77. [ABO AND RH (D) BLOOD GROUPS OF BLOOD DONORS OF THE D'EPARTEMENT DU VAR].
    ANDRE LIARDET J; MOULLEC J; NGUYENVAN CONG
    Transfusion (Paris); 1965; 8():31-6. PubMed ID: 14294193
    [No Abstract]   [Full Text] [Related]  

  • 78. Homozygous HLA-C1 is Associated with Reduced Risk of Relapse after HLA-Matched Transplantation in Patients with Myeloid Leukemia.
    Arima N; Kanda J; Tanaka J; Yabe T; Morishima Y; Kim SW; Najima Y; Ozawa Y; Eto T; Kanamori H; Mori T; Kobayashi N; Kondo T; Nakamae H; Uchida N; Inoue M; Fukuda T; Ichinohe T; Atsuta Y; Kanda Y
    Biol Blood Marrow Transplant; 2018 Apr; 24(4):717-725. PubMed ID: 29197675
    [TBL] [Abstract][Full Text] [Related]  

  • 79. LOW PREVALENCE OF A-ANTIGEN IN CHILDREN WITH ACUTE MYELOID LEUKAEMIA.
    HEWITT D; SPIERS PS
    Lancet; 1964 Jul; 2(7350):93-4. PubMed ID: 14158692
    [No Abstract]   [Full Text] [Related]  

  • 80. Long survival in acute myelogenous leukaemia: an international collaborative study.
    Whittaker JA; Reizenstein P; Callender ST; Cornwell GG; Delamore IW; Gale RP; Gobbi M; Jacobs P; Lantz B; Maiolo AT; Rees JK; Van Slyck EJ; Van HV
    Br Med J (Clin Res Ed); 1981 Feb; 282(6265):692-5. PubMed ID: 6781618
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.